Monash University is calling on healthcare professionals to contribute to the first major draft update to the 2016 Dementia Clinical Practice Guidelines and Principles of Care for People with Dementia.

The proposed update explores advances in dementia care over the past decade, such as new therapies and rehabilitation strategies, protecting brain health, driving assessments, opioid use and end-of-life communication.

It consists of 15 recommendations, including the appropriate use of 18-Fluoro-deoxy glucose Positron Emission Tomography (FDG-PET) and amyloid-PET for diagnosis, as well as biomarkers to both triage and confirm Alzheimer’s disease pathology for those with suspected dementia or mild cognitive impairment.

The proposed recommendations also advise against the use of donanemab or lecanemab for people diagnosed with mild cognitive impairment or mild dementia due to Alzheimer’s disease and suggest deprescribing cholinesterase inhibitors and memantine when the benefits are uncertain or no longer outweigh the risk of harm.